139 related articles for article (PubMed ID: 38669525)
1. Clinical significance of anti-mutated citrullinated vimentin antibodies in rheumatoid arthritis patients.
Hagras A; Mohasseb D; Taleb R; Bastawi R; Elnemr R
Hum Antibodies; 2024; 32(2):75-83. PubMed ID: 38669525
[TBL] [Abstract][Full Text] [Related]
2. Clinical diagnostic significance of 14-3-3η protein, high-mobility group box-1, anti-cyclic citrullinated peptide antibodies, anti-mutated citrullinated vimentin antibodies and rheumatoid factor in rheumatoid arthritis.
Huang J; Zeng T; Zhang X; Tian Y; Wu Y; Yu J; Pei Z; Liu Y; Hu T; Tan L
Br J Biomed Sci; 2020 Jan; 77(1):19-23. PubMed ID: 31433746
[No Abstract] [Full Text] [Related]
3. Comparative analysis of autoantibodies targeting peptidylarginine deiminase type 4, mutated citrullinated vimentin and cyclic citrullinated peptides in rheumatoid arthritis: associations with cytokine profiles, clinical and genetic features.
Reyes-Castillo Z; Palafox-Sánchez CA; Parra-Rojas I; Martínez-Bonilla GE; del Toro-Arreola S; Ramírez-Dueñas MG; Ocampo-Bermudes G; Muñoz-Valle JF
Clin Exp Immunol; 2015 Nov; 182(2):119-31. PubMed ID: 26149185
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic value of anti-mutated citrullinated vimentin in comparison to anti-cyclic citrullinated peptide and anti-viral citrullinated peptide 2 antibodies in rheumatoid arthritis: an Italian multicentric study and review of the literature.
Bartoloni E; Alunno A; Bistoni O; Bizzaro N; Migliorini P; Morozzi G; Doria A; Mathieu A; Lotzniker M; Allegri F; Riccieri V; Alpini C; Gabrielli A; Tampoia M; Gerli R;
Autoimmun Rev; 2012 Sep; 11(11):815-20. PubMed ID: 22394488
[TBL] [Abstract][Full Text] [Related]
5. Anti-MCV antibodies predict radiographic progression in Greek patients with very early (<3 months duration) rheumatoid arthritis.
Barouta G; Katsiari CG; Alexiou I; Liaskos C; Varna A; Bogdanos DP; Germenis AE; Sakkas LI
Clin Rheumatol; 2017 Apr; 36(4):885-894. PubMed ID: 27943044
[TBL] [Abstract][Full Text] [Related]
6. Anti-cyclic citrullinated peptide (anti-CCP) and anti-mutated citrullinated vimentin (anti-MCV) relation with extra-articular manifestations in rheumatoid arthritis.
Gonzalez-Lopez L; Rocha-Muñoz AD; Ponce-Guarneros M; Flores-Chavez A; Salazar-Paramo M; Nava A; Cardona-Muñoz EG; Fajardo-Robledo NS; Zavaleta-Muñiz SA; Garcia-Cobian T; Gamez-Nava JI
J Immunol Res; 2014; 2014():536050. PubMed ID: 24804270
[TBL] [Abstract][Full Text] [Related]
7. Antibodies against citrullinated vimentin in rheumatoid arthritis: higher sensitivity and extended prognostic value concerning future radiographic progression as compared with antibodies against cyclic citrullinated peptides.
Mathsson L; Mullazehi M; Wick MC; Sjöberg O; van Vollenhoven R; Klareskog L; Rönnelid J
Arthritis Rheum; 2008 Jan; 58(1):36-45. PubMed ID: 18163519
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic value of anti-modified citrullinated vimentin in rheumatoid arthritis.
Maraina CH; Nurdayana AK; Rusni D; Azwany Y
Int J Rheum Dis; 2010 Oct; 13(4):335-9. PubMed ID: 21199468
[TBL] [Abstract][Full Text] [Related]
9. Selected cyclic citrullinated peptides derived from the sequence of mutated and citrullinated vimentin (MCV) are targeted by different antibodies subclasses in patients with rheumatoid arthritis in Russian patients.
Derganova O; Martinez-Gamboa L; Egerer K; Bang H; Fredenhagen G; Roggenbuck D; Esaulenko I; Burmester GR; Chernykh T; Feist E
Clin Exp Rheumatol; 2014; 32(5):622-9. PubMed ID: 25189876
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic utility of anti-cyclic citrullinated peptide and anti-modified citrullinated vimentin antibodies in rheumatoid arthritis.
Keskin G; Inal A; Keskin D; Pekel A; Baysal O; Dizer U; Sengül A
Protein Pept Lett; 2008; 15(3):314-7. PubMed ID: 18336364
[TBL] [Abstract][Full Text] [Related]
11. Anti-carbamylated protein antibodies in premenopausal rheumatoid arthritis women: relation to disease activity and bone loss.
Elsawy NA; Mohamed RA; Ghazala RA; Abdelshafy MA; Elnemr R
Rheumatology (Oxford); 2021 Mar; 60(3):1419-1428. PubMed ID: 32995835
[TBL] [Abstract][Full Text] [Related]
12. Prediction of radiographic progression in rheumatoid arthritis and the role of antibodies against mutated citrullinated vimentin: results from a 10-year prospective study.
Syversen SW; Goll GL; van der Heijde D; Landewé R; Lie BA; Odegård S; Uhlig T; Gaarder PI; Kvien TK
Ann Rheum Dis; 2010 Feb; 69(2):345-51. PubMed ID: 19648126
[TBL] [Abstract][Full Text] [Related]
13. Antibodies to mutated citrullinated vimentin in patients with chronic hepatitis C virus genotype IV infection-related arthropathy.
Zehairy M; Soliman E; Daghaidy A
Rheumatol Int; 2012 Nov; 32(11):3495-501. PubMed ID: 22068352
[TBL] [Abstract][Full Text] [Related]
14. Comparison of anti-mutated citrullinated vimentin, anti-cyclic citrullinated peptides, anti-glucose-6-phosphate isomerase and anti-keratin antibodies and rheumatoid factor in the diagnosis of rheumatoid arthritis in Chinese patients.
Zhu T; Feng L
Int J Rheum Dis; 2013 Apr; 16(2):157-61. PubMed ID: 23773638
[TBL] [Abstract][Full Text] [Related]
15. Carbamylated vimentin represents a relevant autoantigen in Latin American (Cuban) rheumatoid arthritis patients.
Martínez G; Gómez JA; Bang H; Martínez-Gamboa L; Roggenbuck D; Burmester GR; Torres B; Prada D; Feist E
Rheumatol Int; 2016 Jun; 36(6):781-91. PubMed ID: 27038800
[TBL] [Abstract][Full Text] [Related]
16. Antibodies against a mutated citrullinated vimentin in patients with rheumatoid arthritis.
Nigm DA; Abdel-Lateef HH; Hashim J; Kamal D
Egypt J Immunol; 2022 Oct; 29(4):184-194. PubMed ID: 36208047
[TBL] [Abstract][Full Text] [Related]
17. A study of the roles of some immunological biomarkers in the diagnosis of rheumatoid arthritis.
Khudhair HAA
J Med Life; 2023 Aug; 16(8):1194-1200. PubMed ID: 38024817
[TBL] [Abstract][Full Text] [Related]
18. The role of anti-mutated citrullinated vimentin antibodies in the diagnosis of early rheumatoid arthritis.
Liu X; Jia R; Zhao J; Li Z
J Rheumatol; 2009 Jun; 36(6):1136-42. PubMed ID: 19447936
[TBL] [Abstract][Full Text] [Related]
19. Anti-mutated citrullinated vimentin antibodies in rheumatoid arthritis; diagnostic utility and association with deformities and disease activity.
Mohammed HS; Ahmed GH; Tawfik NM; Sayed SK; Ahmed AS
Egypt J Immunol; 2023 Jan; 30(1):105-115. PubMed ID: 36592386
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic value of antibodies to modified citrullinated vimentin in early rheumatoid arthritis.
Sizova L
Hum Immunol; 2012 Apr; 73(4):389-92. PubMed ID: 22333689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]